Webinar: What do HCPs really want from pharma digital in 2026?
March 5, 2026 | DigitalExperience, ExperienceDesign, HCPExperience, Pharma, PharmaceuticalIndustry, customerexperience, digitalhealth, userexperience
Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention.
To explore what this means for digital teams, we are hosting a live webinar on 19 March 2026 with senior digital leaders from Novo Nordisk, LEO Pharma and MSD.
Together we will discuss what HCPs truly value from pharma digital and what organisations should prioritise to stay relevant.
To better understand this gap, we recently conducted research exploring how healthcare professionals experience pharma digital today and what they actually value from it. Our study surveyed 225 senior clinicians across the UK, USA and Germany, providing a clear view of how digital engagement is perceived in real-world clinical practice.
One finding stood out in particular. 65% of HCPs told us they have reduced or stopped engaging with a pharma company because of poor digital experiences. Clinicians described filtering out interactions that felt repetitive, overly promotional or difficult to access, while engaging more readily with digital content that was relevant to their clinical context and easy to navigate.
The research suggests that healthcare professionals are not disengaging from pharma digital. Instead, they are becoming more selective. Across our findings, three factors consistently determined whether digital engagement earned attention: relevance, utility and experience.
If content does not clearly relate to an HCP’s specialty or patient population, it is quickly ignored. If it does not help clinicians answer practical questions or support their work, it is unlikely to be revisited. And if the experience itself is difficult or time-consuming, engagement drops quickly.
To explore these themes further, we are hosting a live webinar on 19 March 2026 examining what healthcare professionals really expect from pharma digital in the years ahead.
The session will be hosted by our CEO, Rob Verheul, who will be joined by senior digital leaders from across the pharmaceutical industry:
- Iria Gala, VP Digital & Customer Engagement at Novo Nordisk
- Ryan Twiname, Head of Global Digital Marketing and Customer Engagement at LEO Pharma
- Yazan Iwidat, Global Omnichannel Experience Standards Lead at MSD
For teams responsible for digital engagement, omnichannel strategy or HCP experience, the conversation will offer practical insight into how organisations can close the growing gap between digital activity and digital value.
This content was provided by Graphite Digital
Company Details
Latest Content from Graphite Digital
What do HCPs want from pharma medical information sites in 2026?
At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine those conversations with wider sector…
Bridging the value gap: The systems, teams and mindsets that matter
In pharma, the challenge is no longer understanding what HCPs want from digital. It’s delivering it consistently. In this webinar, we explored what needs to change inside organisations to make…
Webinar: What do HCPs really want from pharma digital in 2026?
Our research shows that healthcare professionals are not disengaging from pharma digital. They are becoming more selective about the experiences that earn their attention. To explore what this means for…
The strategic role of AI in scaling Design Systems across channels
How can pharma teams scale AI safely across channels? In this session, Ed Hart and Nicolas Barcza explore why strong Design Systems are the foundation for making AI operational, compliant…
What HCPs want from digital pharma in 2026: The value gap
We’re proud to share Graphite’s 2026 research report. An in-depth look at how healthcare professionals experience digital engagement with life sciences today, and where the value gap is widening.
First impressions matter: Why getting your onboarding right is key for digital engagement
As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,…
Pharma’s digital dilemma: Finding the balance between speed, scale, and experience
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick…
Redefining digital ROI: Engagement, experience, and the new metrics of success
Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and…
5 key digital CX challenges in pharma, and how to start solving them
Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are…
The digital reality check: How pharma measures up in 2025
Download your copy of our latest pharma white paper, exploring the latest digital trends, challenges and opportunities in pharma.